Amgen Inc

AMGNNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026Score 17/3039% above fair value

$465.45−0.56 (-0.12%)

Close on Nov 2, 2026Market cap $251.64BP/E 28.9Yield 2.08%

Amgen MVASI (bevacizumab-awwb by Year

Name: Amgen MVASI (bevacizumab-awwb by Year (AMGN)
Creator: Amgen

MVASI (bevacizumab-awwb — Avastin Oncology Biosimilar) — Worldwide product sales ($M) ($M)

Quarterly Annual

Amgen MVASI (bevacizumab-awwb: $771M in FY2025, up 6.1% from a year earlier.

Latest, FY2025

771

Period ended Dec 31, 2025

Change on a year earlier

+6.1%

727 in FY2024

History

7 years

Since FY2019

Sources

Documents cited below

Where the FY2025 figure comes from

“|| MVASI ® | 573 | 198 | 771 | 727 | 6%”

Source: Form 8-K (amgn-20251231earningsrelea.htm, filed 2026-02-03) ↗

Reported in Form 10-Q / 10-K Segment & Revenue Disaggregation Note & Form 8-K Product Sales Detail.

Annual history

Hover a value to see the sentence it was read from; calculated values show their formula

Period	Ended	MVASI (bevacizumab-awwb — Avastin Oncology Biosimilar) — Worldwide product sales ($M) ($M)	Year on year	Source
FY2025	Dec 31, 2025	771	+6.1%	Form 8-K (amgn-20251231earningsrelea.htm, filed 2026-02-03) ↗
FY2024	Dec 31, 2024	727	-9.1%	Form 8-K (amgn-20241231earningsrelea.htm, filed 2025-02-04) ↗
FY2023	Dec 31, 2023	800	-11.2%	Form 8-K (amgn-20231231earningsrelea.htm, filed 2024-02-06) ↗
FY2022	Dec 31, 2022	901	-22.7%	Form 8-K (amgn-20221231earningsrelea.htm, filed 2023-01-31) ↗
FY2021	Dec 31, 2021	1,166	+46.1%	Form 8-K (amgenq42021earningsrelease.htm, filed 2022-02-07) ↗
FY2020	Dec 31, 2020	798	+528.3%	Form 8-K (amgn-20201231xq4ex991.htm, filed 2021-02-02) ↗
FY2019	Dec 31, 2019	127	–	Form 8-K (amgn-20191231xq4ex991.htm, filed 2020-01-30) ↗

Breakdown

What makes up MVASI (bevacizumab-awwb

Cite this data

StockData. (2026). Amgen MVASI (bevacizumab-awwb ($M), annual FY2019–FY2025 [Data set]. Compiled from Amgen SEC filings and investor materials. https://stockdatahq.com/stocks/amgn/kpis/prod-mvasi-ww

See every metric in the Amgen KPI table. Data updated Oct 28, 2026.